Outcomes of HIV treatment from the private sector in low-income and middle-income countries: a systematic review protocol

Abstract

IntroductionPrivate sector provision of HIV treatment is increasing in low-income and middle-income countries (LMIC). However, there is limited documentation of its outcomes. This protocol reports a proposed systematic review that will synthesise clinical outcomes of private sector HIV treatment in LMIC.Methods and analysisThis review will be conducted in accordance with the preferred reporting items for systematic review and meta-analyses protocols. Primary outcomes will include: (1) proportion of eligible patients initiating antiretroviral therapy (ART); (2) proportion of those on ART with <1000 copies/mL; (3) rate of all-cause mortality among ART recipients. Secondary outcomes will include: (1) proportion receivingPneumocystis jirovecipneumonia prophylaxis; (2) proportion with >90% ART adherence (based on any measure reported); (3) proportion screened for non-communicable diseases (specifically cervical cancer, diabetes, hypertension and mental ill health); (iv) proportion screened for tuberculosis. A search of five electronic bibliographical databases (Embase, Medline, PsychINFO, Web of Science and CINAHL) and reference lists of included articles will be conducted to identify relevant articles reporting HIV clinical outcomes. Searches will be limited to LMIC. No age, publication date, study-design or language limits will be applied. Authors of relevant studies will be contacted for clarification. Two reviewers will independently screen citations and abstracts, identify full text articles for inclusion, extract data and appraise the quality and bias of included studies. Outcome data will be pooled to generate aggregative proportions of primary and secondary outcomes. Descriptive statistics and a narrative synthesis will be presented. Heterogeneity and sensitivity assessments will be conducted to aid interpretation of results.Ethics and disseminationThe results of this review will be disseminated through a peer-reviewed scientific manuscript and at international scientific conferences. Results will inform quality improvement strategies, replication of identified good practices, potential policy changes, and future research.PROSPERO registration numberCRD42016040053.

Intersectional stigma and its impact on HIV prevention and care among MSM and WSW in sub-Saharan African countries: a protocol for a scoping review

“…We, however, anticipate to disseminate findings to the public, with special attention to audiences involved in HIV research and practice in order to inform decision-making in healthcare practice and policy. 31…”

Smartphone Use and Willingness to Pay for HIV Treatment-Assisted Smartphone Applications among HIV-Positive Patients in Urban Clinics of Vietnam

“…Antiretroviral treatment (ART) has been regarded as the most effective treatment regime to improve patients' immune system function and to limit the risk of HIV transmission [1][2][3]. The rapid expansion of ART services has reduced the epidemic spread and brought benefits to approximately 21.8 million people living with HIV/AIDS in lowand middle-income nations [4]. However, people living with HIV/AIDS must remain on lifelong treatment and strictly adhere to ART regimens to prevent drug resistance and to achieve treatment success [5,6].…”

SARS-CoV-2 epidemic: causes and current situation, historical lessons, and strategical therapeutic interventions

“…HIV still infects people in many countries including, Canada, India, United States, Mexico, Germany, Brazil, Indonesia and Iran. To date, HIV has infected 75 million people; 32 million have died and many are still dying each year 5,6 . The details of viruses which have previously caused global pandemics and which are still infecting world population are outlined in Table 1.…”